BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28277310)

  • 41. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication.
    Peralta V; Campos MS; de Jalon EG; Cuesta MJ
    Schizophr Res; 2010 May; 118(1-3):168-75. PubMed ID: 20071147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Remission and relapse after the first hospital admission in psychotic depression: a 4-year naturalistic follow-up.
    Naz B; Craig TJ; Bromet EJ; Finch SJ; Fochtmann LJ; Carlson GA
    Psychol Med; 2007 Aug; 37(8):1173-81. PubMed ID: 17335639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment and violent behavior in persons with first episode psychosis during a 10-year prospective follow-up study.
    Langeveld J; Bjørkly S; Auestad B; Barder H; Evensen J; Ten Velden Hegelstad W; Joa I; Johannessen JO; Larsen TK; Melle I; Opjordsmoen S; Røssberg JI; Rund BR; Simonsen E; Vaglum P; McGlashan T; Friis S
    Schizophr Res; 2014 Jul; 156(2-3):272-6. PubMed ID: 24837683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perceptions of relapse risks following first-episode psychosis and attitudes towards maintenance medication: a comparison between nursing and social work professionals.
    Chan KK; Chin QP; Tang JY; Longenecker J; Hui CL; Chiu CP; Lam MM; Wong GH; Chen EY
    Early Interv Psychiatry; 2011 Nov; 5(4):324-34. PubMed ID: 21521490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Schneider's first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis.
    Malinowski FR; Tasso BC; Ortiz BB; Higuchi CH; Noto C; Belangero SI; Bressan RA; Gadelha A; Cordeiro Q
    Braz J Psychiatry; 2020; 42(1):22-26. PubMed ID: 31166544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
    Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
    Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis.
    Lambert M; Conus P; Cotton S; Robinson J; McGorry PD; Schimmelmann BG
    J Clin Psychopharmacol; 2010 Oct; 30(5):565-72. PubMed ID: 20814327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis.
    Winton-Brown TT; Elanjithara T; Power P; Coentre R; Blanco-Polaina P; McGuire P
    Schizophr Res; 2017 Jan; 179():50-56. PubMed ID: 27745754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interictal psychoses in comparison with schizophrenia--a prospective study.
    Tadokoro Y; Oshima T; Kanemoto K
    Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of 'all-cause discontinuation' of initial oral antipsychotic medication in first episode psychosis.
    Mustafa S; Joober R; Lepage M; Iyer S; Shah J; Malla A
    Schizophr Res; 2018 Nov; 201():287-293. PubMed ID: 29706449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical recovery in first-episode psychosis.
    Wunderink L; Sytema S; Nienhuis FJ; Wiersma D
    Schizophr Bull; 2009 Mar; 35(2):362-9. PubMed ID: 18990715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.
    Janssen B; Gaebel W; Haerter M; Komaharadi F; Lindel B; Weinmann S
    Psychopharmacology (Berl); 2006 Aug; 187(2):229-36. PubMed ID: 16710714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of a single psychotic episode: a 7.5-year, prospective study in first-episode psychosis.
    Alvarez-Jimenez M; Gleeson JF; Henry LP; Harrigan SM; Harris MG; Amminger GP; Killackey E; Yung AR; Herrman H; Jackson HJ; McGorry PD
    Schizophr Res; 2011 Feb; 125(2-3):236-46. PubMed ID: 21081266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medication-adherent first-episode psychosis patients also relapse: why?
    Levy E; Pawliuk N; Joober R; Abadi S; Malla A
    Can J Psychiatry; 2012 Feb; 57(2):78-84. PubMed ID: 22340147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
    Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
    J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of symptom resolution on medication adherence in first episode psychosis.
    Steger KA; Cassidy C; Rabinovitch M; Joober R; Malla A
    Psychiatry Res; 2012 Mar; 196(1):45-51. PubMed ID: 22377571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission.
    Ketter TA; Agid O; Kapur S; Loebel A; Siu CO; Romano SJ
    J Psychiatr Res; 2010 Jan; 44(1):8-14. PubMed ID: 19699488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.